{"id":"W4390125958","doi":"10.1016/j.jval.2023.09.391","title":"EE121 Cost-Efficiency and the Opportunity for Expanded Treatment Access with Incremental Increases in Biosimilar Adalimumab and Tocilizumab Use: A European Perspective","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Biosimilar; Tocilizumab; Adalimumab; Perspective (graphical); Medicine; Internal medicine; Computer science; Rheumatoid arthritis; Artificial intelligence","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001775927,0.0001837613,0.0003871561,0.0001698149,0.0002284069,0.000044483,0.0001288643,0.00007959392,0.00001844535],"category_scores_gemma":[0.0003708713,0.0001067007,0.00003878907,0.0003760743,0.0004813792,0.00008892672,0.0001245307,0.000170264,0.000001382365],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002279717,"about_ca_system_score_gemma":0.0002139527,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01528314,"about_ca_topic_score_gemma":0.001130469,"domain_scores_codex":[0.997287,0.001549814,0.0003249707,0.0003884472,0.0000433106,0.000406429],"domain_scores_gemma":[0.9984974,0.001108359,0.0001036866,0.0001816726,0.00003917002,0.00006974235],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.06394411,0.009746188,0.4978504,0.001738742,0.002189774,0.0005969669,0.04993892,0.000628598,0.005953509,0.1135291,0.00663393,0.2472498],"study_design_scores_gemma":[0.1462643,0.01849926,0.7275708,0.00171902,0.0003993555,0.0006397187,0.05560746,0.01126093,0.00603233,0.01062161,0.01917687,0.002208267],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9872188,0.003205754,0.00009331321,0.006288185,0.00006147115,0.002586548,0.0002055286,0.0000525916,0.0002878316],"genre_scores_gemma":[0.9962391,0.002374223,0.0002054779,0.0008805325,0.00001450623,0.0001316312,0.00002805648,0.00001576866,0.0001106617],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2450415,"threshold_uncertainty_score":0.9912742,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1502631327678599,"score_gpt":0.3781046183827965,"score_spread":0.2278414856149366,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}